The Effects of the Farm Bill to Hemp-Derived CBD Market

New Post Public Reply Private Reply Replies (0) Message Board
Kgem
257
The Effects of the Farm Bill to Hemp-Derived CBD Market Growth

Brightfield Group expects the passing of the Farm Bill will open the CBD market in four key ways:

1. Strategic Marketing

Current laws are extremely limiting in terms of how CBD products can be marketed to consumers. The Farm Bill will legalize hemp-based CBD at the federal level making it easy for CBD companies to advertise their products the same way other nutraceutical brands do. With more marketing, more consumers will become aware of CBD products and sales will increase.

2. Distribution Channels

Today, the majority of CBD product sales occur online. The Brightfield Group’s research discovered that in 2018, CBD product sales are taking place through six channels:

• Natural food stores (29%)
• Online sales (24%)
• Smoke shops (23%)
• Medical companies (6%)
• Dispensaries (6%)
• Other channels (12%) such as multi-level marketing companies, specialized CBD retailers, gas stations and convenience stores, gyms, and independent pharmacies.

When the Farm Bill passes, Brightfield predicts national retailers like Walmart, pharmacies like CVS, supermarkets, pharmaceutical companies, and a variety of other channels will start carrying CBD products. In 2022, Brightfield expects the majority of CBD product sales will happen through chained retailers and other more conventional and mainstream supplement retail channels (e.g., natural food stores and alternative medicine practitioners).

3. Changing Consumer Sentiments

Many consumers today view hemp (the source of hemp-derived CBD products) similarly to marijuana (which includes THC, the component that creates the high effect) since they come from the same plant (cannabis) and are both illegal at the federal level. However, the passing of the Farm Bill will show consumers that hemp and marijuana are actually very different.

Hemp has been gaining popularity among consumers in recent years and as more CBD products are available on traditional retailers’ shelves, much of the stigma around them will disappear. At this point, CBD companies will have opportunities to build their brands, making the market ripe for mergers and acquisitions.

4. Product Variety and Innovation

Already, CBD product companies have launched a wide variety of products for various uses. Edibles, tinctures, creams, pills, and more are available, but the number of product types and innovations – both in terms of manufacturing and use cases – will continue to grow when it becomes easier to cultivate and source hemp for manufacturing, cross state lines with it, and conduct research with it. With more product choices comes more competition in the market. Inevitably, sales will go up and the market will grow.

CBD Market Trends

As the CBD market grows quickly in multiple directions, much of the market trends are now based on consumer demands. Consumer demands for lab testing have been on the rise with education about possible contaminations in hemp products. Heavy metals, pesticides, herbicides, and fungicides are some of the common culprits.
In addition, consumer demands are pushing for a wider variety of products which will shape the industry in the future. “The biggest push right now is CBD everything, consumers can find CBD in coffee, lotions, snacks, teas, water, workout supplements, and more.

CBD Brand Development

As CBD products become more mainstream in terms of consumers being able to purchase them at their local grocery stores, on Amazon, and so on, there is a growing concern about finding brands that are trustworthy and offer high quality products. Lab testing is the best way for brands to establish their reputations as trustworthy and offering high quality products. Specifically, batch testing from verified third-party labs is critical. We come in contact with many companies that are selling products tainted with contaminants, that have less CBD or cannabinoids than what they claim on the bottle, or those that will send a lab report from years back when requested. You should be able to call up a company or email them and get a timely response to any of your questions.

Build a solid foundation of integrity and then allow that to come through your brand presence and interactions. There’s no such thing as too much testing. Be transparent and honest. Be supportive and informative to your customers. Get to understand the requirements for GMP certification and be ready for a visit from the FDA. It can happen, and if you’re not ready with all of your documents and processes in line, it can end your company. Invest in marketing materials, labels, a website, and so on so your customers can have a relationship with your brand and company.

Tips for Entrepreneurs and Investors Entering the CBD Market

Entering the CBD market today isn’t like entering many other markets. While that might change if the Farm Bill is passed, there are some aspects of owning all or a piece of a hemp-derived CBD company that you can still expect. If you want to start a business in this industry, build solid relationships with your farmers and ingredient suppliers and always have backups. Always request a sample for your own testing before signing any contracts. For longevity’s sake, act with integrity and do the right thing. Honesty goes a long way. Importantly, never make medical claims unless you’re looking for a letter from the FDA.”

The Future of the Hemp-Derived CBD Market

Assuming the Farm Bill passes, marketing and manufacturing will open up in the CBD market, and major retailers and pharmaceutical companies will enter the market. As a result, “Hemp CBD will transition from a grassroots movement largely driven by word-of-mouth marketing into a full-fledged competitor on the nutraceutical market, driving the whopping 132% compound annual growth rate (CAGR) expected over the five year projection period.”

In addition, Brightfield Group predicts the market will continue to grow after the Farm Bill opens the doors to expanded funding for research that will drive pharmaceutical and other research money into the market. This will increase the number and variety of uses for hemp-derived CBD as well as consumer interest in CBD products.
In other words, the CBD market will continue growing in the future, but when the Farm Bill passes, that growth will speed up exponentially to the tune of $22 billion in 2022.

https://www.cannabisbusinessexecutive.com/201...-264326777



Univec Conglomerate Inc (UNVC) Stock Research Links

UNVC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Testing Grounds: Navigating PRN Test Insights

Updated Category News Views 1

Deciphering the PRN Tester Repetition Today we're staring at what feels like déjà vu—a simple PR test peppered with the classic sentence about a fox and a dog. It's like someone left the 'repeat' function stuck on during a slow day at the office. But hey, let’s dig in. Is there something more behind this repetitive text, or are we grumbling at a wall? Unpacking the...

Continue Reading
TECNO's Modular Phone and Mini-PC Win Big at IFA 2026

Updated Category News Views 1

The Tale of Two Game-Changers TECNO has just scooped up two big-time awards, and I'm here to break it down like no glossy magazine ever could. Picture this: a brand that knows how to keep its foot on the innovation pedal and doesn't shy away from shaking up the tech world. TECNO's got the goods, claiming two prestigious IFA Global Product Technology Innovation Awards this...

Continue Reading
HKC and KOORUI Shine Bright at 2026 Berlin Awards

Updated Category News Views 3

Display Titans Take Center Stage in Berlin Look, in this game of display tech, you either adapt or get left in the dust. At the 2026 Global Product Technology Innovation Awards in Berlin, we saw two names rise to the top—HKC and its acclaimed brand KOORUI. They didn't just show up; they grabbed the spotlight with two major honors. Award Spotlights: A Breakdown HKC took...

Continue Reading
Signant and Lothar Forge Future in Clinical Trials

Updated Category News Views 2

Breathing New Life into Clinical Trials Alright, folks, listen up. We've got a fresh collaboration cooking that could shake things up in the clinical trial sector. Signant Health, a heavyweight in clinical trial solutions, has teamed up with Lothar Medical, and they’ve hitched their wagons to launch something rather intriguing: the ALDS PRO pulmonary function tech. Let...

Continue Reading
LiberNovo Spotlights Ergonomic Seating at Berlin's IFA 2026

Updated Category News Views 1

LiberNovo Sets the Stage at IFA 2026 If you're poking around Berlin this September, the Messe Berlin is the place to be, especially for those keeping tabs on the consumer tech world. LiberNovo, the ergonomic seating company you might not have had on your radar, is out here making noise. They're throwing down the gauntlet with the Maxis Series, promising a better deal for...

Continue Reading
Affleck Joins Aflac in Unlikely Yet Fitting Alliance

Updated Category News Views 2

A Partnership Born from a Punning Connection Look, in this world of insurance and Hollywood glitz, it's not every day you see Ben Affleck sharing the screen with a talking duck. But here we are. Aflac—the giant in supplemental health insurance—and Ben Affleck have cozied up for a series of ads under Affleck’s direction, breathing life into what started as nothing...

Continue Reading
Hims & Hers Faces Legal Storm Over Alleged Privacy Breaches

Updated Category News Views 4

Legal Storms Brew Over Alleged Privacy Breaches Well, here we go again, folks. Just when you think the waters are calming, Hims & Hers Health, Inc. (NYSE: HIMS) finds itself in the thick of a nasty securities fraud class action lawsuit. Allegedly they've been less than honest with their customers' health info—something about sneaking around with people's sensitive data...

Continue Reading
Evolve & ELITEWHEELS: Shifting Gears in European Cycling

Updated Category News Views 3

Revving Up for the European Cycling Scene There's something about the open road and the whirr of wheels that gets blood pumping—maybe it's the competition, maybe it's the gear. Either way, this year's Italian Bike Festival is turning the Misano World Circuit into a battleground for cycling's elite, with evolve and ELITEWHEELS charging at the forefront. They're not just...

Continue Reading
Virterion Surges Ahead in VPS Racing With Reliable Hosting

Updated Category News Views 3

Why Virterion Stands Out in 2026 VPS Landscape For anyone knee-deep in the hosting game, you know the market's got more players than a late-night poker round. Virterion, though—that's a name carving out a noticeable niche, and for solid reasons. In 2026, the backdrop's not just speed, it’s about matching technology and support with what ambitious developers need. VPS...

Continue Reading
Roborock Fuels Market Surge with 27.6% Revenue Boost

Updated Category News Views 1

Roborock's Rocket-Like Ascent in Global Markets Call me impressed, but Roborock is really hitting its stride. The company's been on a tear, pulling in RMB 10.084 billion during the first half of 2026—a remarkable 27.6% bump from last year. Not just content with the revenue surge, they also saw net profits jump 45.6%, making it pretty clear that they're not just playing...

Continue Reading

Top 5 Most Recently Viewed Articles

Talisker Resources Successfully Closes Gold-Linked Note Deal

Updated Category News Views 49

Talisker Resources Announces Successful Financing Initiative Talisker Resources Ltd. (TSK) has made headlines with the completion of its latest financing venture involving $1.33 million through the issuance of gold-linked notes. This strategic move is set to propel the progress of Talisker's flagship project, the Bralorne Gold Project, which is currently undergoing...

Continue Reading
FDA Approves Novartis' Kisqali, Expanding Breast Cancer Treatment

Updated Category News Views 133

FDA Approves Novartis' Kisqali: A Major Step Forward in Breast Cancer Care Novartis (NYSE: NVS) has reached a crucial milestone with the FDA's approval of Kisqali (ribociclib), now available for a broader group of patients facing early-stage breast cancer. This approval represents a significant leap in treating hormone receptor-positive/human epidermal growth factor...

Continue Reading
Mounting Challenges for Mobileye N.V: Insights into Stock Outlook

Updated Category News Views 101

Mobileye Faces Downgrade as Transition Year Approaches Recently, UBS has revised its outlook on Mobileye N.V (NASDAQ:MBLY), a leader in autonomous driving technologies. The firm has downgraded the stock from Buy to Neutral, with a lowered price target of $14.00, decreasing from an earlier target of $20.00. This decision is primarily due to the company's current struggles,...

Continue Reading
Plans for Spending Cuts and Subsidy Eliminations Revealed

Updated Category News Views 118

Plans for Federal Spending Cuts and Subsidy Eliminations John Paulson, a billionaire investor known for his connections with former President Donald Trump, has outlined his strategy for significant federal spending reductions if he were to be appointed as Treasury Secretary. Collaborating with Elon Musk, Paulson seeks to minimize government expenditures, particularly by...

Continue Reading
Brazil’s Finance Minister Prepares for Key Fiscal Announcements

Updated Category News Views 35

Brazil's Finance Minister Prepares for Key Fiscal Announcements Brazil's Finance Minister Fernando Haddad has recently indicated that significant fiscal measures aimed at supporting the country’s financial framework might be unveiled shortly. This announcement comes as the government approaches the final stages of preparation for what could be a pivotal moment in...

Continue Reading